Latest & greatest articles for stroke

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on stroke or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on stroke and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for stroke

1. Better balance: a randomised controlled trial of oculomotor and gaze stability exercises to reduce risk of falling after stroke

Better balance: a randomised controlled trial of oculomotor and gaze stability exercises to reduce risk of falling after stroke Better balance: a randomised controlled trial of oculomotor and gaze stability exercises to reduce risk of falling after stroke - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) balance: a randomised controlled trial of oculomotor and gaze stability exercises to reduce risk of falling after stroke , , , Affiliations Expand Affiliations 1 Physiotherapy, Hospital Curry Cabral, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal. Teaching and Research Unit of Physiotherapy and Rehabilitation, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Portugal. 2 Epidemiology and Statistics Office of the Research Unit, Centro Hospitalar

2020 EvidenceUpdates

2. Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial (Full text)

Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Neurology Actions . 2020 Aug 25;95(8):e1091-e1104. doi: 10.1212/WNL.0000000000010038. Epub 2020 Jun 26. Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled

2020 EvidenceUpdates PubMed abstract

3. Motor imagery for gait rehabilitation after stroke. (Abstract)

Motor imagery for gait rehabilitation after stroke. Motor imagery (MI) is defined as a mentally rehearsed task in which movement is imagined but is not performed. The approach includes repetitive imagined body movements or rehearsing imagined acts to improve motor performance.To assess the treatment effects of MI for enhancing ability to walk among people following stroke.We searched the Cochrane Stroke Group registry, CENTRAL, MEDLINE, Embase and seven other databases. We also searched trial (...) registries and reference lists. The last searches were conducted on 24 February 2020.Randomized controlled trials (RCTs) using MI alone or associated with action observation or physical practice to improve gait in individuals after stroke. The critical outcome was the ability to walk, assessed using either a continuous variable (walking speed) or a dichotomous variable (dependence on personal assistance). Important outcomes included walking endurance, motor function, functional mobility, and adverse

2020 Cochrane

4. In ischemic stroke, thrombectomy alone was noninferior to thrombectomy plus alteplase for functional outcome at 90 days. (Abstract)

In ischemic stroke, thrombectomy alone was noninferior to thrombectomy plus alteplase for functional outcome at 90 days. Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020;382:1981-93. 32374959.

2020 Annals of Internal Medicine

5. In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortality. (Abstract)

In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortality. Chiarito M, Sanz-Sánchez J, Cannata F, et al. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. Lancet. 2020;395;1487-95. 32386592.

2020 Annals of Internal Medicine

6. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial (Full text)

stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2-15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching (...) Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID

2020 EvidenceUpdates PubMed abstract

7. Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association (Full text)

Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search September (...) 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association , MD, Chair , MD, MPH, Vice Chair , MD , MD, FAHA

2020 American Heart Association PubMed abstract

8. Does cycling induced by functional electrical stimulation enhance motor recovery in the subacute phase after stroke? A systematic review and meta-analysis (Full text)

Does cycling induced by functional electrical stimulation enhance motor recovery in the subacute phase after stroke? A systematic review and meta-analysis Does cycling induced by functional electrical stimulation enhance motor recovery in the subacute phase after stroke? A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) : 10.1177/0269215520938423. Online ahead of print. Does cycling induced by functional electrical stimulation enhance motor recovery in the subacute phase after stroke? A systematic review and meta-analysis , , , , Affiliations Expand Affiliations 1 Neuroengineering and Medical Robotics Laboratory, Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, MI, Italy. 2 Bioengineering Laboratory, Scientific Institute of Milan, Istituti Clinici Scientifici Maugeri IRCCS, Milan

2020 EvidenceUpdates PubMed abstract

9. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

to help to detect atrial fibrillation after cryptogenic stroke, including transient ischaemic attacks (TIA), only if: • non-invasive electrocardiogram (ECG) monitoring has been done and • a cardiac arrhythmic cause of stroke is still suspected. 1.2 Clinicians should consider if disabled people may need support from a carer to help set up the MyCareLink Patient Monitor, to ensure data from Reveal LINQ are transmitted for review. 1.3 There is not enough evidence to recommend the routine adoption (...) muscle that cause atrial fibrillation can be persistent, permanent or intermittent. Paroxysmal atrial fibrillation involves intermittent episodes that usually last less than 2 days and stop without treatment. Cryptogenic stroke Cryptogenic stroke 2.2 Cryptogenic strokes (including transient ischaemic attack [TIA]) have no identified probable cause after diagnostic assessment, and account for around 15% to 40% of ischaemic strokes. When people have treatment for stroke, they are tested for atrial

2020 National Institute for Health and Clinical Excellence - Diagnostics Guidance

10. Using co-production to increase activity in acute stroke units: the CREATE mixed-methods study (Full text)

Using co-production to increase activity in acute stroke units: the CREATE mixed-methods study Using co-production to increase activity in acute stroke units: the CREATE mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue (...) {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} The study showed that experience-based co-design approach would be feasible to implement into acute stroke units, there were improvements in the unit environment and increased activity opportunities for patients. {{author}} {{($index , , , , , , , & . Fiona Jones 1, * , Karolina Gombert-Waldron 1 , Stephanie Honey 2 , Geoffrey Cloud 3 , Ruth Harris 4 , Alastair Macdonald 5 , Chris McKevitt 6 , Glenn Robert 4 , David

2020 NIHR HTA programme PubMed abstract

11. Temporal variations in quality of acute stroke care and outcomes in London hyperacute stroke units: a mixed-methods study (Full text)

Temporal variations in quality of acute stroke care and outcomes in London hyperacute stroke units: a mixed-methods study Temporal variations in quality of acute stroke care and outcomes in London hyperacute stroke units: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above (...) to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Organisational factors influence 24/7 provision of stroke care, creating temporal patterns of provision reflected in patient outcomes, including mortality, length of stay and functional independence. {{author}} {{($index , , , , , , , , , , & . Robert Simister 1 , Georgia B Black 2, * , Mariya Melnychuk 2 , Angus IG Ramsay 2 , Abigail Baim-Lance 3 , David L Cohen 4

2020 NIHR HTA programme PubMed abstract

12. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. (Abstract)

undergoing a noncardiac surgery (postoperative AF) between 2000 and 2013. Of these patients, 452 were matched 1:1 on age, sex, year of surgery, and type of surgery to patients with noncardiac surgery who were not diagnosed with AF within 30 days following the surgery (no AF). The last date of follow-up was December 31, 2018.Postoperative AF vs no AF after noncardiac surgery.The primary outcome was ischemic stroke or transient ischemic attack (TIA). Secondary outcomes included subsequent documented AF (...) Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. Outcomes of postoperative atrial fibrillation (AF) after noncardiac surgery are not well defined.To determine the association of new-onset postoperative AF vs no AF after noncardiac surgery with risk of nonfatal and fatal outcomes.Retrospective cohort study in Olmsted County, Minnesota, involving 550 patients who had their first-ever documented AF within 30 days after

2020 JAMA

13. Citicoline for treating people with acute ischemic stroke. (Abstract)

Citicoline for treating people with acute ischemic stroke. Stroke is one of the leading causes of long-lasting disability and mortality and its global burden has increased in the past two decades. Several therapies have been proposed for the recovery from, and treatment of, ischemic stroke. One of them is citicoline. This review assessed the benefits and harms of citicoline for treating patients with acute ischemic stroke.To assess the clinical benefits and harms of citicoline compared (...) with placebo or any other control for treating people with acute ischemic stroke.We searched in the Cochrane Stroke Group Trials Register, CENTRAL, MEDLINE Ovid, Embase Ovid, LILACS until 29 January 2020. We searched the World Health Organization Clinical Trials Search Portal and ClinicalTrials.gov. Additionally, we also reviewed reference lists of the retrieved publications and review articles, and searched the websites of the US Food and Drug Administration (FDA) and European Medicines Agency (EMA).We

2020 Cochrane

14. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack. (Abstract)

Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack. Stroke is a leading cause of morbidity and mortality worldwide. Antiplatelet agents are considered to be the cornerstone for secondary prevention of stroke, but the role of using multiple antiplatelet agents early after stroke or transient ischaemic attack (TIA) to improve outcomes has not been established.To determine the effectiveness and safety of initiating, within (...) ; composite outcome of stroke, myocardial infarction, and vascular death; intracranial haemorrhage; extracranial haemorrhage; ischaemic stroke; death from all causes; and haemorrhagic stroke. We computed an estimate of treatment effect and performed a test for heterogeneity between trials. We analysed data on an intention-to-treat basis and assessed bias for all studies. We rated the certainty of the evidence using the GRADE approach.We included 15 RCTs with a total of 17,091 participants. Compared

2020 Cochrane

15. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review

Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Stroke Actions . 2020 Jul;51(7):2244-2248. doi: 10.1161/STROKEAHA.120.029340. Epub 2020 Jun 5. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke

2020 EvidenceUpdates

16. Apixaban - venous thromboembolism, DVT and stroke

Apixaban - venous thromboembolism, DVT and stroke Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. EMA/296798/2020 EMEA/H/C/005358 Apixaban Accord (apixaban) An overview of Apixaban (...) stroke (caused by blood clots in the brain) and blood clots in other organs in adults with atrial fibrillation (irregular rapid contractions of the upper chambers of the heart). It is used in patients who have one or more risk factors, such as having had a previous stroke, having high blood pressure, diabetes, heart failure or being 75 years old or over. Apixaban Accord contains the active substance apixaban. Apixaban Accord is a ‘generic medicine’. This means that Apixaban Accord contains the same

2020 European Medicines Agency - EPARs

17. Antithrombotic treatment in patients with stroke and supracardiac atherosclerosis

in patients with stroke and supracardiac atherosclerosis using the terms "anticoagulant or anticoagulation" and "antiplatelet or aspirin" and "randomized controlled trial or RCT" and "stroke or cerebral ischemia" and "aortic or carotid or vertebrobasilar or intracranial or atherosclerosis or stenosis or arterial." Four outcomes were assessed: recurrent ischemic stroke, major ischemic event or death, major bleeding, and intracranial bleeding. Treatment effects (relative risk [RR] and 95% confidence (...) interval [CI]) were estimated by meta-analysis using random-effects models. Results: Among 1,117 articles identified in the literature search, results from 10 randomized controlled trials involving 6,068 patients with stroke/TIA with supracardiac atherosclerosis were included in the meta-analysis. Recurrent ischemic stroke rates were 2.94 per 100 patient-years in the anticoagulant-assigned patients vs 3.30 per 100 patient-years in the antiplatelet-assigned patients (RR, 0.91; 95% CI, 0.70-1.18

2020 EvidenceUpdates

18. Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis (Full text)

small vessel disease progression. Methods: A systematic review and meta-analysis of unconfounded randomized controlled trials of cilostazol to prevent stroke, cognitive decline, or radiological small vessel disease lesion progression. Two reviewers searched for papers (January 1, 2019 to July 16, 2019) and extracted data. We calculated Peto odds ratios (ORs) and 95% CIs for recurrent ischemic, hemorrhagic stroke, death, adverse symptoms, with sensitivity analyses. The review is registered (...) (CRD42018084742). Results: We included 20 randomized controlled trials (n=10 505), 18 in ischemic stroke (total n=10 449) and 2 in cognitive impairment (n=56); most were performed in Asia-Pacific countries. Cilostazol decreased recurrent ischemic stroke (17 trials, n=10 225, OR=0.68 [95% CI, 0.57-0.81]; P <0.0001), hemorrhagic stroke (16 trials, n=9736, OR=0.43 [95% CI, 0.29-0.64]; P =0.0001), deaths (OR=0.64 [95% CI, 0.49-0.83], P <0.0009), systemic bleeding (n=8387, OR=0.73 [95% CI, 0.54-0.99]; P =0.04

2020 EvidenceUpdates PubMed abstract

19. Resistance training in stroke rehabilitation: systematic review and meta-analysis

Resistance training in stroke rehabilitation: systematic review and meta-analysis Resistance training in stroke rehabilitation: systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get the latest (...) : Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Clin Rehabil Actions . 2020 Sep;34(9):1173-1197. doi: 10.1177/0269215520932964. Epub 2020 Jun 11. Resistance training in stroke rehabilitation: systematic review and meta-analysis , Affiliations Expand Affiliation 1 Faculty of Psychology, Education and Sport Science

2020 EvidenceUpdates

20. Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data (Full text)

Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Stroke Actions . 2020 Aug;51(8):2322-2331. doi: 10.1161/STROKEAHA.119.028396. Epub 2020 Jul 2. Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data , , , , Affiliations Expand

2020 EvidenceUpdates PubMed abstract